Filing identity and reporting period
Important mismatch: The request identifies Red Cat Holdings, Inc., but the supplied filing is Broadleaf Capital Partners, Inc.’s Form 10-K for the fiscal year ended December 31, 2012. It reports annual results, not a standalone 2012 fourth-quarter period. The summary below reflects the filing provided and should not be attributed to Red Cat without verification.
Business context
Broadleaf describes itself as a diversified investment holding company seeking new investments and business opportunities after selling its interest in Canyon Shadows Apartments in the first quarter of 2012. It also reports starting Pipeline Nutrition USA, Inc., a sports-nutrition supplement subsidiary, in 2012; the filing says Pipeline generated sales and built inventory and distribution.
Financial results and condition
| Metric | 2012 | 2011 |
|---|---|---|
| Revenue / sales | $31,744 | Conflicting disclosure: $7,600 in MD&A; $0 in the audited statement of operations |
| Cost of sales | $24,471 | $0 |
| Gross profit | $7,273 | $7,600 per audited statement |
| Selling, general and administrative expense | $230,391 | $53,777 |
| Net income (loss) | $851,928 | $(84,736) |
| Operating cash flow | $(269,185) | $(59,523) |
| Cash at year-end | $107,627 | $11,957 |
| Total assets | $151,205 | $36,924 |
| Total liabilities | $102,536 | $1,082,409 |
| Stockholders’ equity (deficit) | $48,669 | $(1,045,485) in MD&A; audited balance sheet shows $(1,045,485) in its narrative and $(1,045,485) is not consistent with the displayed equity line of $(1,045,485)? |
The audited balance sheet’s displayed 2011 equity total is $(1,045,485); its component figures appear to total a different amount, so verify against the original filing. 2012 current liabilities were $102,536, including $30,383 of notes payable; no long-term debt was reported. Working capital based on reported current assets and current liabilities was $48,669.
2012 earnings were driven primarily by a $927,318 gain on the Canyon Shadows sale and $138,238 of debt-forgiveness income, rather than recurring operations. Interest expense was $9,490, down from $38,576 in 2011. Cash from the investment sale was $952,285; the company used $587,430 for note payments. Operating activities consumed cash despite reported net income.
Material changes and notable items
- Liabilities fell by about $980,000 year over year, principally following the investment sale and debt repayments; reported equity moved from deficit to positive.
- Common shares outstanding rose from 144,419,925 at year-end 2011 to 167,097,874 at year-end 2012. The company issued shares for debt settlements and services, including 16 million shares for interest and 5.625 million shares as consulting compensation, as described in the filing.
- Pipeline Nutrition contributed new sales, but the company reported $24,471 of cost of sales and increased startup and administrative costs.
- No dividends had been paid, and the company did not expect to pay them in the foreseeable future.
Outlook, risks and controls
Management intended to fund operations from remaining cash while seeking joint ventures, acquisitions, or other investments; it also discussed possible additional capital and conversions of notes into shares. No quantified financial guidance was provided. Management gave no assurance these plans would succeed.
The auditor’s report raises substantial doubt about the company’s ability to continue as a going concern, citing its accumulated deficit and dependence on financing or profitable operations. The filing reports an accumulated deficit of $14,259,936 at December 31, 2012. Management concluded disclosure controls and internal control over financial reporting were ineffective and identified a material weakness associated with limited personnel and resources; the company had no audit committee or audit committee financial expert. The auditor did not attest to internal controls.
Other risks include limited trading liquidity, penny-stock status, potential dilution from future financing, slow economic activity, and uncertainty over using net operating loss carryforwards. The filing states there are no open legal proceedings, while also disclosing remaining liabilities. It reports no material off-balance-sheet arrangements.
Important facts for investors to verify
- Confirm the issuer: the supplied report is for Broadleaf Capital Partners, Inc., not Red Cat Holdings, Inc.
- Reconcile the 2011 sales and gross-profit figures: MD&A reports $7,600 of revenue, while the audited statement reports $0 sales and $7,600 gross profit.
- Check the reported 2011 equity and balance-sheet totals against the original filing; the extracted figures are inconsistent.
- Verify whether cash and remaining liabilities provide adequate runway, given negative operating cash flow and the auditor’s going-concern warning.
- Assess the quality and repeatability of 2012 earnings, which depended chiefly on an investment-sale gain and debt forgiveness, and review dilution from share issuances.